Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Ynddal
L. Ynddal
Novo Nordisk
Endocrinology
Pharmacodynamics
Pharmacokinetics
Medicine
Internal medicine
3
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice
2003
Diabetes, Obesity and Metabolism
P. MacKay
L. Ynddal
J. V. Andersen
J. G. McCormack
Show All
Source
Cite
Save
Citations (14)
The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects.
2001
Growth Hormone & Igf Research
Milan Zdravkovic
Tina Christiansen
L. Eliot
H. Agersoe
M.S. Thomsen
J.F. Falch
B. Søgaard
L. Ynddal
Mapoko M. Ilondo
Show All
Source
Cite
Save
Citations (10)
The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers
2000
Growth Hormone & Igf Research
Milan Zdravkovic
B. Søgaard
L. Ynddal
Tina Christiansen
Henrik Agersø
M.S. Thomsen
J.E. Falch
Mapoko M. Ilondo
Show All
Source
Cite
Save
Citations (15)
1